Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002533729 | SCV000834062 | uncertain significance | Blau syndrome; Regional enteritis | 2023-12-27 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 925 of the NOD2 protein (p.Asp925Gly). This variant is present in population databases (rs545734771, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with NOD2-related conditions. ClinVar contains an entry for this variant (Variation ID: 581298). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NOD2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002534429 | SCV003702118 | uncertain significance | Inborn genetic diseases | 2021-09-01 | criteria provided, single submitter | clinical testing | The c.2774A>G (p.D925G) alteration is located in exon 8 (coding exon 8) of the NOD2 gene. This alteration results from a A to G substitution at nucleotide position 2774, causing the aspartic acid (D) at amino acid position 925 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003907958 | SCV004725091 | uncertain significance | NOD2-related condition | 2024-02-01 | criteria provided, single submitter | clinical testing | The NOD2 c.2774A>G variant is predicted to result in the amino acid substitution p.Asp925Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.011% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |